APA (7th ed.) Citation

Penn-Nicholson, A., Georghiou, S. B., Ciobanu, N., Kazi, M., Bhalla, M., David, A., . . . Consortium, X. X. T. (2022). Detection of isoniazid, fluoroquinolone, ethionamide, amikacin, kanamycin, and capreomycin resistance by the Xpert MTB/XDR assay: A cross-sectional multicentre diagnostic accuracy study. Lancet Infectious Diseases, 22(2), 242. https://doi.org/10.1016/S1473-3099(21)00452-7

Chicago Style (17th ed.) Citation

Penn-Nicholson, Adam, et al. "Detection of Isoniazid, Fluoroquinolone, Ethionamide, Amikacin, Kanamycin, and Capreomycin Resistance by the Xpert MTB/XDR Assay: A Cross-sectional Multicentre Diagnostic Accuracy Study." Lancet Infectious Diseases 22, no. 2 (2022): 242. https://doi.org/10.1016/S1473-3099(21)00452-7.

MLA (9th ed.) Citation

Penn-Nicholson, Adam, et al. "Detection of Isoniazid, Fluoroquinolone, Ethionamide, Amikacin, Kanamycin, and Capreomycin Resistance by the Xpert MTB/XDR Assay: A Cross-sectional Multicentre Diagnostic Accuracy Study." Lancet Infectious Diseases, vol. 22, no. 2, 2022, p. 242, https://doi.org/10.1016/S1473-3099(21)00452-7.